ATE247475T1 - Synthetische gangliosid-derivate - Google Patents

Synthetische gangliosid-derivate

Info

Publication number
ATE247475T1
ATE247475T1 AT95933807T AT95933807T ATE247475T1 AT E247475 T1 ATE247475 T1 AT E247475T1 AT 95933807 T AT95933807 T AT 95933807T AT 95933807 T AT95933807 T AT 95933807T AT E247475 T1 ATE247475 T1 AT E247475T1
Authority
AT
Austria
Prior art keywords
ganglioside derivatives
synthetic ganglioside
suppressing
immune response
synthetic
Prior art date
Application number
AT95933807T
Other languages
English (en)
Inventor
Stephan Ladisch
Akira Hasegawa
Original Assignee
Stephan Ladisch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stephan Ladisch filed Critical Stephan Ladisch
Application granted granted Critical
Publication of ATE247475T1 publication Critical patent/ATE247475T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AT95933807T 1994-09-14 1995-09-14 Synthetische gangliosid-derivate ATE247475T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/305,832 US5567684A (en) 1994-09-14 1994-09-14 Synthetic ganglioside derivatives
PCT/US1995/011670 WO1996008257A1 (en) 1994-09-14 1995-09-14 Synthetic ganglioside derivatives

Publications (1)

Publication Number Publication Date
ATE247475T1 true ATE247475T1 (de) 2003-09-15

Family

ID=23182557

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933807T ATE247475T1 (de) 1994-09-14 1995-09-14 Synthetische gangliosid-derivate

Country Status (8)

Country Link
US (1) US5567684A (de)
EP (1) EP0783311B1 (de)
JP (2) JP4727767B2 (de)
AT (1) ATE247475T1 (de)
AU (1) AU3632395A (de)
CA (1) CA2199809C (de)
DE (1) DE69531546T2 (de)
WO (1) WO1996008257A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
AU683026B2 (en) * 1992-10-22 1997-10-30 Kirin Pharma Kabushiki Kaisha Novel shingoglycolipid and use thereof
CA2160566C (en) * 1993-04-15 2004-07-13 Tatsuo Higa Novel sphingoglycolipids and uses thereof
JPH08176185A (ja) * 1994-12-19 1996-07-09 Toa Boshoku Kk 糖脂質合成中間体
CA2459040A1 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
DE10226367A1 (de) * 2002-06-13 2003-12-24 Nutricia Nv Ganglioside mit modifizierter Acylfunktion
CA2682738A1 (en) 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Defined glycoprotein products and related methods
US9921210B2 (en) 2010-04-07 2018-03-20 Momenta Pharmaceuticals, Inc. High mannose glycans
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
US20150210753A1 (en) 2012-07-26 2015-07-30 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388309A (en) * 1981-06-10 1983-06-14 Shanksville Corporation, N.V. Process for suppressing graft rejection in organ transplantation
JPS59164798A (ja) * 1983-03-09 1984-09-17 Rikagaku Kenkyusho シアル酸含有糖脂質誘導体
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1208751B (it) * 1986-06-30 1989-07-10 Fidia Farmaceutici Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali
JP2588729B2 (ja) * 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体
JP2782069B2 (ja) * 1988-08-12 1998-07-30 和光純薬工業株式会社 ガングリオシド類の新規な製造法
JPH02307974A (ja) * 1989-05-19 1990-12-21 Nippon Fine Chem Co Ltd セルロース系素材及びその加工品の改質剤
JPH03255028A (ja) * 1990-03-01 1991-11-13 Imeeji Meekaa:Kk 免疫抑制剤
JPH0476082A (ja) * 1990-07-18 1992-03-10 Shiseido Co Ltd ゲル化剤
US5371202A (en) * 1991-02-28 1994-12-06 The Nisshin Oil Mills, Ltd. Processes of preparing sialoglycosyl compounds
JPH04300891A (ja) * 1991-03-29 1992-10-23 Nisshin Oil Mills Ltd:The S−グリコシドを有するガングリオシド類縁体
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
JPH04353570A (ja) * 1991-05-31 1992-12-08 Asai Bussan Kk 防曇性樹脂組成物、防曇性成形体および防曇方法
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
JPH07228514A (ja) * 1993-12-21 1995-08-29 Nippon Fine Chem Co Ltd 酸化染毛剤組成物

Also Published As

Publication number Publication date
AU3632395A (en) 1996-03-29
JP2007262085A (ja) 2007-10-11
CA2199809C (en) 2008-07-29
EP0783311A4 (de) 1998-12-23
JP5165283B2 (ja) 2013-03-21
DE69531546T2 (de) 2004-06-17
DE69531546D1 (de) 2003-09-25
EP0783311A1 (de) 1997-07-16
EP0783311B1 (de) 2003-08-20
JP4727767B2 (ja) 2011-07-20
WO1996008257A1 (en) 1996-03-21
US5567684A (en) 1996-10-22
JPH10508829A (ja) 1998-09-02
CA2199809A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
DE69531546D1 (de) Synthetische gangliosid-derivate
KR860005001A (ko) 세제 조성물
BG103485A (en) Ketobanzamides as calpain inhibitors
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
CA2174033A1 (fr) Nouveaux composes pyridiniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CA2109934A1 (en) Substituted indoles as anti-aids pharmaceuticals
CA2119853A1 (fr) Nouvelles pyridothiadiazines, leurs procedes de preparation, et les compositions pharmaceutiques qui les contiennent
ATE16488T1 (de) M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
NO924598D0 (no) Fremstilling av substituerte piperidiner
NO173549C (no) Nye organiske forbindelser, fremgangsmaate for fremstilling derav, og anvendelse derav
CA2037975A1 (en) 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors
CA2257479A1 (en) Soap bar composition
BR8004499A (pt) Composicoes de aclaradores oticos e sua aplicacao
DE3070768D1 (en) 1-((substituted-naphthyl)ethyl)-imidazole derivatives, pharmaceutical compositions containing them and methods of making them
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
DE3264556D1 (en) Sulfimines, their salts and their preparation, and pharmaceutical compositions containing them
ES8502700A1 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
ES2058196T3 (es) Derivados de azacromano.
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
FI922518A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi
IT1237506B (it) Derivati amminici di 2,3-diaza-antracene-9,10-dioni come farmaci antitumorali
DK0485894T3 (da) Fremgangsmåde til fremstilling af semisyntetiske diastereomerrene N-glycidyl-anthracycliner
MX9706968A (es) Compuesto de tiocarbamoilo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties